The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
120 jobs Number of planned job losses
Announcement Date
3 May 2011
Employment effect (start)
Foreseen end date
Description
Pharmaceutical manufacturer Warner Chilcota has announced its decision of dismissing its 120 employees working in Spain. The affected workers are all working in pharmaceutical sales. The dismissals are part of a Europe-wide restructuring plan which will result in the loss of 500 jobs in Germany, France, Italy, Belgium, Netherlands and Switzerland.
The main reason behind this restructuring is the growing competition from generic medicines and the loss of exclusive rights to sell the Actomen medicine in 2010. As of may 2011, there is no information on when the job cuts will be implemented by.
Sources
3 May 2011: Cinco Días
Citation
Eurofound (2011), Warner Chilcott, Closure in Spain, factsheet number 71918, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71918.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
